Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Barels who wrote (801)	4/8/1998 3:54:00 PM
From: StockDoc	Read Replies (1) of 887

Thanks for the news, this fact-based analysis and stock price projection of DepoTech sounds right. They still have some investor money to burn (i.e., redistribute), and then that's it. Assume DepoCyt gets approved (and I win the California lottery tonight) and sells 15 M/year (2500 patients/year, $ 6000/patient ?). 50% of that (remember, Chiron takes the other half) is not enough to keep them in business. Then comes the sucker, and then what? If anyone is dreaming out there, DepoMorphine will not make it. It can't be titrated and therefore too dangerous for postop analgesia. Patient controlled analgesia will knock it out in the first round of comparative trials on safety. Hey Bob, let's go somewhere else. Any good ideas? Did you hear something exciting at the meeting? StockDoc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next